AbbVie
ABBV
#26
Rank
โ‚น35.895 T
Marketcap
โ‚น20,310
Share price
-1.15%
Change (1 day)
39.89%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Cash on Hand

Cash on Hand as of September 2025 : โ‚น509.46 Billion

According to AbbVie's latest financial reports the company has โ‚น509.46 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

AbbVie - Cash on Hand chart (from 2011 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚น476.54 B-55.33%
2023-12-31โ‚น1.066 T39.7%
2022-12-31โ‚น763.70 B4.38%
2021-12-31โ‚น731.65 B17.99%
2020-12-31โ‚น620.10 B-78.22%
2019-12-31โ‚น2.847 T405.11%
2018-12-31โ‚น563.64 B-9.82%
2017-12-31โ‚น625.03 B43.2%
2016-12-31โ‚น436.47 B-21.88%
2015-12-31โ‚น558.68 B5.27%
2014-12-31โ‚น530.72 B-13.18%
2013-12-31โ‚น611.31 B39.98%
2012-12-31โ‚น436.70 B1164.22%
2011-12-31โ‚น34.54 B7054.46%
2010-12-31โ‚น0.48 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
โ‚น1.346 T 164.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น1.482 T 190.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น890.59 B 74.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น848.50 B 66.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น660.20 B 29.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น355.78 B-30.16%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น399.26 B-21.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
โ‚น735.04 B 44.28%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น100.14 B-80.34%๐Ÿ‡บ๐Ÿ‡ธ USA